We are live on ! Find out more
FGP

Foyston, Gordon, & Payne Portfolio holdings

AUM $434M
1-Year Est. Return 9.09%
This Fund
S&P 500
This Quarter Est. Return
+14.03%
1 Year Est. Return
+9.09%
3 Year Est. Return
+56.86%
5 Year Est. Return
+84.63%
10 Year Est. Return
+238.52%
AUM
$407M
AUM Growth
+$22.3M
Cap. Flow
-$27.7M
Cap. Flow %
-6.79%
Top 10 Hldgs %
50.05%
Holding
63
New
3
Increased
10
Reduced
42
Closed

Top Buys

Rank Stock Value
1
OTIS icon
Otis Worldwide
OTIS
+$10.5M
2
LHX icon
L3Harris
LHX
+$5.02M
3
MSI icon
Motorola Solutions
MSI
+$3.53M
4
SONY icon
Sony
SONY
+$2.29M
5
MDLZ icon
Mondelez International
MDLZ
+$1.74M

Top Sells

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$11.1M
2
AON icon
Aon
AON
+$7.06M
3
MSFT icon
Microsoft
MSFT
+$4.84M
4
MDT icon
Medtronic
MDT
+$4.24M
5
CSCO icon
Cisco
CSCO
+$3.16M

Sector Composition

Rank Sector Weight
1 Healthcare 27.27%
2 Technology 25.38%
3 Industrials 15.24%
4 Consumer Staples 13.17%
5 Financials 6.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.83T
$41.5M 10.18%
203,699
-26,688
-12% -$4.84M
JNJ icon
2
Johnson & Johnson
JNJ
$624B
$29.7M 7.3%
211,537
-17,227
-8% -$2.51M
MDT icon
3
Medtronic
MDT
$105B
$24.3M 5.97%
265,014
-44,211
-14% -$4.24M
CSCO icon
4
Cisco
CSCO
$444B
$20.9M 5.13%
447,968
-72,089
-14% -$3.16M
UNH icon
5
UnitedHealth
UNH
$385B
$20.6M 5.06%
69,867
-7,680
-10% -$2.2M
MSI icon
6
Motorola Solutions
MSI
$67.6B
$18.4M 4.52%
131,357
+24,936
+23% +$3.53M
RTX icon
7
RTX Corp
RTX
$282B
$12.9M 3.16%
209,072
-178,177
-46% -$11.1M
PM icon
8
Philip Morris
PM
$298B
$12.2M 2.98%
173,542
-6,779
-4% -$494K
BKNG icon
9
Booking.com
BKNG
$134B
$11.9M 2.93%
187,450
-22,500
-11% -$1.37M
OTIS icon
10
Otis Worldwide
OTIS
$27.2B
$11.5M 2.83%
+202,789
New +$10.5M
BAX icon
11
Baxter International
BAX
$11.2B
$11.3M 2.77%
131,057
-5,704
-4% -$497K
MDLZ icon
12
Mondelez International
MDLZ
$77.1B
$9.76M 2.39%
190,816
+33,934
+22% +$1.74M
CTVA icon
13
Corteva
CTVA
$59.4B
$8.41M 2.06%
313,780
-173
-0.1% -$4.5K
PEP icon
14
PepsiCo
PEP
$184B
$7.55M 1.85%
57,080
-2,356
-4% -$311K
CHRW icon
15
C.H. Robinson
CHRW
$24.2B
$7.28M 1.79%
92,110
-13,501
-13% -$1.02M
ZBRA icon
16
Zebra Technologies
ZBRA
$12.2B
$7.28M 1.79%
28,433
-295
-1% -$69.1K
PFE icon
17
Pfizer
PFE
$143B
$6.99M 1.72%
225,268
+30,461
+16% +$1.03M
AXP icon
18
American Express
AXP
$233B
$6.98M 1.71%
73,285
-4,984
-6% -$459K
AON icon
19
Aon
AON
$76B
$6.95M 1.7%
36,063
-37,864
-51% -$7.06M
HSY icon
20
Hershey
HSY
$34.9B
$6.76M 1.66%
52,155
-830
-2% -$112K
MRSH
21
Marsh
MRSH
$84.2B
$6.47M 1.59%
60,248
+2,787
+5% +$282K
META icon
22
Meta Platforms (Facebook)
META
$1.54T
$6.28M 1.54%
27,667
-2,479
-8% -$518K
SBUX icon
23
Starbucks
SBUX
$118B
$5.9M 1.45%
80,164
-2,409
-3% -$181K
UNP icon
24
Union Pacific
UNP
$181B
$5.78M 1.42%
34,210
-8,090
-19% -$1.3M
AOS icon
25
A.O. Smith
AOS
$8.2B
$5.48M 1.34%
116,215
-10,702
-8% -$467K

Similar funds

Foyston, Gordon, & Payne's Q2 2020 Portfolio in Review

As of Q2 2020, Foyston, Gordon, & Payne held 63 positions worth $407M, up 5.8% from $385M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Foyston, Gordon, & Payne withdrew a net $27.7M in Q2 2020, reducing 42 holdings. Its largest reduction was RTX Corp, cutting an estimated $11.1M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 30% a quarter earlier, followed by Technology and Industrials.

Against the trend, Foyston, Gordon, & Payne opened a new position in Otis Worldwide worth $11.5M.

  • Foyston, Gordon, & Payne's largest Q2 2020 buy was Otis Worldwide: 202,789 shares worth $11.5M.
  • Foyston, Gordon, & Payne added most to Motorola Solutions in Q2 2020, an estimated $3.53M increase.
  • Foyston, Gordon, & Payne's biggest Q2 2020 reduction was RTX Corp, cutting an estimated $11.1M.
  • Foyston, Gordon, & Payne's ten largest holdings make up 50% of its $407M portfolio in Q2 2020.
  • Foyston, Gordon, & Payne opened 3 new positions and closed 0 in Q2 2020.
  • Foyston, Gordon, & Payne's portfolio value rose 5.8% quarter-over-quarter to $407M.

Based on Foyston, Gordon, & Payne's 13F filing for Q2 2020, filed 14 Aug 2020.